Total nominal spending on medicines in the U.S. from 2002 to 2022 (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you U.S. pharmaceutical industry
Contribution to global pharma
5
- Premium Statistic World pharmaceutical market distribution by submarket 2014-2023
- Premium Statistic World pharmaceutical sales 2020-2023 by region
- Basic Statistic Market share of the leading global pharmaceutical markets 2022
- Premium Statistic Top global pharmaceutical markets: growth rate 2022
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
Overview
6
- Premium Statistic U.S. total medicine spending 2002-2022
- Basic Statistic Leading therapy areas for U.S. drug spending 2020
- Premium Statistic U.S. top prescribed drugs based on sales 2022
- Premium Statistic Top pharma products by prescriptions U.S. 2021
- Premium Statistic Pharmaceutical channel distribution by U.S. spending 2017-2019
- Premium Statistic U.S. biopharmaceutical export volume 2002-2022
Companies
6
- Premium Statistic 2024 list of top U.S. biotech and pharmaceutical companies based on revenue
- Premium Statistic Pharmaceutical corporations by U.S. revenue 2022
- Basic Statistic AbbVie's revenue 2010-2023
- Premium Statistic Pfizer's total revenue 2006-2023
- Premium Statistic Bristol-Myers Squibb's revenue 2006-2023
- Premium Statistic Johnson & Johnson's total sales 2005-2023
Research and development
7
- Basic Statistic Research and development expenditure: U.S. pharmaceutical industry 1995-2022
- Premium Statistic U.S. pharma industry R&D spending as a percent of total revenues 1990-2022
- Basic Statistic Pharmaceuticals: cost of drug development in the U.S. since 1975
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2023
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Basic Statistic U.S. sales of new brand medicines 2012-2021
- Basic Statistic R&D expenditure per employee in U.S. sectors 2003-2017
Generics
5
- Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
- Premium Statistic U.S. brand and generic prescription drug spending 2017-2021
- Premium Statistic Branded vs. generic U.S. drug prescriptions dispensed 2005-2021
- Premium Statistic Savings through generic drug usage in the U.S. 2008-2022
- Premium Statistic Sales share at risk of pharmaceuticals due to patent expiries U.S. 2022
Public view on pharma
6
- Premium Statistic Share of U.S. people who had a favorable view of pharmaceutical companies 2021
- Premium Statistic U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
- Premium Statistic Share of U.S. adults who approve pharmaceutical companies' drug price handling 2021
- Basic Statistic Share of people who had a favorable view of Pfizer in U.S. 2021
- Basic Statistic Share of people who had a favorable view of Moderna in U.S. 2021
- Premium Statistic Share of people who had a favorable view of J&J in U.S. 2021
Outlook
4
- Premium Statistic World pharmaceutical sales by region forecast 2027
- Premium Statistic Sales at risk of pharmaceuticals due to patent expiries U.S. 2022
- Basic Statistic Leading U.S. pharmaceutical products by revenue 2026
- Basic Statistic U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection
Further related statistics
17
- Volume of the ten best-selling drugs in France 2015, by packaging
- Volume of the ten best-selling drugs in France 2015, by active ingredient
- U.S. spending on specialty medicine by type 2014-2018
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- U.S. spending on biosimilars by type 2014
- Compensation of dispensed antidepressants in the Netherlands 2014-2022
- Biologic share of total pharmaceutical sales in select countries 2018
- Manufacture of opium alkaloids and derivatives by type U.S. 2013-2022
- Canada's biologic share of pharmaceutical sales 2009-2018
- Spend on medicines in primary care in the UK 2010/11-2016/17, by type
- U.S. hospitals with select levels of medication price markups 2017
- Rx medicine out-of-pocket expense per person by age in the U.S. 1987-2014
- Rx medicine out-of-pocket expense per person by insurance status 1987-2014
- Annual testosterone drug revenue in the United States 2013 and 2018
- Share of new orphan drugs available in Europe in 2023, by country
- Monthly value of medicament exports from Finland 2022-2023
Further Content: You might find this interesting as well
Statistics
- Volume of the ten best-selling drugs in France 2015, by packaging
- Volume of the ten best-selling drugs in France 2015, by active ingredient
- U.S. spending on specialty medicine by type 2014-2018
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- U.S. spending on biosimilars by type 2014
- Compensation of dispensed antidepressants in the Netherlands 2014-2022
- Biologic share of total pharmaceutical sales in select countries 2018
- Manufacture of opium alkaloids and derivatives by type U.S. 2013-2022
- Canada's biologic share of pharmaceutical sales 2009-2018
- Spend on medicines in primary care in the UK 2010/11-2016/17, by type
- U.S. hospitals with select levels of medication price markups 2017
- Rx medicine out-of-pocket expense per person by age in the U.S. 1987-2014
- Rx medicine out-of-pocket expense per person by insurance status 1987-2014
- Annual testosterone drug revenue in the United States 2013 and 2018
- Share of new orphan drugs available in Europe in 2023, by country
- Monthly value of medicament exports from Finland 2022-2023
IQVIA. (May 2, 2023). Total nominal spending on medicines in the U.S. from 2002 to 2022 (in billion U.S. dollars) [Graph]. In Statista. Retrieved May 23, 2024, from https://www.statista.com/statistics/238689/us-total-expenditure-on-medicine/
IQVIA. "Total nominal spending on medicines in the U.S. from 2002 to 2022 (in billion U.S. dollars)." Chart. May 2, 2023. Statista. Accessed May 23, 2024. https://www.statista.com/statistics/238689/us-total-expenditure-on-medicine/
IQVIA. (2023). Total nominal spending on medicines in the U.S. from 2002 to 2022 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: May 23, 2024. https://www.statista.com/statistics/238689/us-total-expenditure-on-medicine/
IQVIA. "Total Nominal Spending on Medicines in The U.S. from 2002 to 2022 (in Billion U.S. Dollars)." Statista, Statista Inc., 2 May 2023, https://www.statista.com/statistics/238689/us-total-expenditure-on-medicine/
IQVIA, Total nominal spending on medicines in the U.S. from 2002 to 2022 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/238689/us-total-expenditure-on-medicine/ (last visited May 23, 2024)
Total nominal spending on medicines in the U.S. from 2002 to 2022 (in billion U.S. dollars) [Graph], IQVIA, May 2, 2023. [Online]. Available: https://www.statista.com/statistics/238689/us-total-expenditure-on-medicine/